Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06382727
Other study ID # ER008
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 2024
Est. completion date April 2025

Study information

Verified date April 2024
Source The Alfred
Contact Emma Ridley, A/Prof
Phone +61 3 9903 0350
Email emma.ridley@monash.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Critically ill patients admitted to the Intensive Care Unit (ICU) often need to be connected to a breathing machine (ventilator) and are unable to eat. During this time, liquid nutrition is delivered via a feeding tube to the stomach or bowel (termed enteral nutrition (EN)) to ensure nutrition needs are provided until such time that the patient can eat normally. The delivery of nutrition via EN is frequently interrupted due to procedures and changes in the gastrointestinal system that can cause digestion to be slow. One of the main contributors to EN interruptions is fasting prior to removal of the breathing tube (termed extubation). The practice of pausing EN prior to the removal of the breathing tube is historical and based on evidence for patients who are not within the ICU. There is currently no scientific consensus on whether pausing of EN is necessary, or for how long. Because of this, some clinicians choose to pause EN prior to removal of the breathing tube and some clinicians continue to provide EN. This study is a pilot randomised controlled trial of fasting patients for at least 4 hours prior to removal of the breathing tube compared with not pausing EN. The investigators hypothesise that this will reduce the number of hours of fasting in the 24 hours prior to extubation.


Description:

The provision of EN is standard practice to mechanically ventilated patients within the ICU. Delivery is frequently interrupted, with patients often receiving approximately half of prescribed volumes. One of the main contributors to this is fasting prior to extubation. Fasting prior to extubation is historically informed from pre-anaesthetic practice in patients who are not critically ill where fasting allows for adequate gastric emptying and reduces the risk of aspiration on induction. The practice of fasting prior to extubation is less informed, and variable. A recent scoping review identified only 1 randomised controlled trial (RCT) and 13 observational studies on this topic. The review found fasting durations varied between 0-34 hours and the reasons for fasting prior to extubation were safety related; however, these reasons were often extrapolated from data outside of the ICU as outlined above. The review concluded that there is an evidence gap and no evidence-based consensus as to the rationale and duration of fasting critically ill patients prior to extubation. The clinical consequences of fasting (and particularly repeated fasting) are not well understood; however, it is known that fasting leads to reduced nutrition which may negatively impact response to illness, particularly in patients with a long length of stay. Beyond this, the requirement for fasting may delay extubation and progression of care (as extubation may be cancelled if the patient is not adequately fasted) and lead to unnecessary use for nursing and medical resources. The CONTINUE trial represents the first trial of its kind in Australia and seeks to determine feasibility to inform a program of research that addresses a universal practice for critically ill patients requiring mechanical ventilation. Establishment of feasibility will provide data to inform a large RCT of similar nature, powered to determine differences in important clinical outcomes such as reintubation rate, ventilator free days to day 28 of admission and development of aspiration pneumonia. The culmination of this research will be to create an evidence-based guideline on pre-extubation fasting with the aim of standardising and informing international practice. The primary aim is to determine whether continuing EN to the point of extubation and performing maximal nasogastric aspiration immediately prior is feasible and decreases total fasting in the time 24 hours prior to extubation compared to standard practice of ceasing EN 4- 6 hours prior to planned extubation, in low risk ventilated patients. Secondary objectives include assessment of important safety related endpoints including change in oxygenation requirements, aspiration, reintubation rate at 48 hours after extubation and clinical outcome measures including ICU and hospital morbidity and mortality.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date April 2025
Est. primary completion date April 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years or older - Receiving invasive mechanical ventilation > 24 hours and < 10 days in the index ICU admission - Receiving EN at a rate = 30ml/hr - Planned for extubation within the hours of 0800-1800 Exclusion Criteria: - EN delivery via a fine bore nasogastric tube that is unable to be aspirated - A single gastric residual volume = the maximum protocol limit at the participating site has been recorded within the last 24 hours - Currently receiving extracorporeal membrane oxygenation - Acute neurological pathology - A time critical medication is required via the enteral route (including anti-parkinsons and immunosuppressant medication) and no adjustments can be made - Pre-existing swallow, bulbar dysfunction and/or concern around inadequate airway protection - A laparotomy has been performed within 72 hours of planned extubation - Confirmed pregnancy - Patient not deemed appropriate to be reintubated in the event of deterioration - Treating clinician believes enrolment is not in the best interests of the patient

Study Design


Related Conditions & MeSH terms


Intervention

Other:
EN will be continued up to extubation (EN will not be withheld prior to extubation)
As per the arm/group descriptions.

Locations

Country Name City State
Australia St Vincent's Hospital Melbourne Fitzroy Victoria
Australia The Alfred Hospital Melbourne Victoria
Australia Gold Coast University Hospital Southport Queensland

Sponsors (1)

Lead Sponsor Collaborator
Emma Ridley

Country where clinical trial is conducted

Australia, 

References & Publications (1)

Varghese JA, Tatucu-Babet OA, Miller E, Lambell K, Deane AM, Burrell AJC, Ridley EJ. Fasting practices of enteral nutrition delivery for airway procedures in critically ill adult patients: A scoping review. J Crit Care. 2022 Dec;72:154144. doi: 10.1016/j.jcrc.2022.154144. Epub 2022 Sep 15. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Fasting time (hours) Fasting time due to planned extubation 24 hours prior to endotracheal tube removal
Secondary Reintubation rate Actual reintubation rate and according to an objective criterion for failure:
Respiratory acidosis (pH <7.35 with Paco2 >45 mm Hg); Spo2 less than 90% or Pao2 less than 60 mm Hg at Fio2 greater than 0.4; Respiratory rate greater than 35/min; Decreased level of consciousness (defined as a decrease in GCS score >1 point); Agitation, or clinical signs suggestive of respiratory muscle fatigue, increased work of breathing (eg, the use of respiratory accessory muscles, paradoxical abdominal motion, or retraction of the intercostal spaces), or both; Patients dying within 72 hours will also be considered as extubation failures.
48 hours post endotracheal tube removal
Secondary Days alive and free of mechanical ventilation Number of days alive and free of mechanical ventilation Up to day 28 post randomisation
Secondary Commencement of antibiotics Commencement of antibiotics for a chest infection or aspiration Up to 7 days post endotracheal tube removal
Secondary Ratio of oxygen saturation (SpO2)/ fraction of inspired oxygen (FiO2) SpO2:FiO2 ratio 12 hours post endotracheal tube removal
Secondary ICU length of stay ICU length of stay (days) Up to day 28 post randomisation
Secondary In-hospital mortality In-hospital mortality during ICU or acute ward admission Up to day 28 post randomisation
Secondary Nutrition delivery The absolute and relative (to calculated requirements) amount of calories delivered 24 hours prior to endotracheal tube removal
Secondary Recruitment rate Number of patients recruited per month Up to the end of the study period
Secondary Protocol compliance Defined as the proportion of patients receiving the allocated intervention Up to Endotracheal Tube removal
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness